Urogen Pharma Ltd (URGN)

Operating Expenses

$238.11M

TTM · Period ending: · USD

URGN logo

URGN Operating Expenses

Latest reported$238.11M
URGN TTM Operating Expenses ($16.70M → $238.11M)
High-resolution chart · PNG

URGN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
238,109,000
234,449,000
222,204,000
218,293,000
206,999,000
190,344,000
178,299,000
164,400,000
156,089,000
144,709,000
138,888,000
139,146,000
139,325,000
138,720,000
135,744,000
134,133,000
135,516,000
136,471,000
135,177,000
135,245,000
133,974,000
131,670,000
137,529,000
142,800,000
133,977,000
125,624,000
109,496,000
93,674,000
90,538,000
85,247,000
76,505,000
62,686,000
50,189,000
37,660,000
27,508,000
20,911,000
19,201,000
16,645,000
16,704,000
20,132,000
16,056,000
13,843,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.